Trending News

Blog Post

Market

Israeli study shows 4th shot of COVID-19 vaccine not able to block Omicron By Reuters 



© Reuters. 93-year-old Shari Marco receives a fourth dose of the coronavirus disease (COVID-19) vaccine following a vaccination party after Israel approved a second booster shot for the immunocompromised, people over 60 years and medical staff in a retirement home i

JERUSALEM (Reuters) – A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it likely is not enough to prevent Omicron infections, according to a preliminary study in Israel.

The vaccines led to a increase in the number of antibodies “even a little bit higher than what we had after the third dose”, said Regev-Yochay, adding that the results were preliminary and not yet published.

Israel was the fastest country to roll out initial vaccinations a year ago and last month started offering a fourth shot, or a second booster, to the most vulnerable, high-risk groups.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Related posts

Leave a Reply

Required fields are marked *